HEMODYNAMIC-EFFECTS OF THE USE OF ORAL SNUFF

被引:22
作者
HIRSCH, JM
HEDNER, J
WERNSTEDT, L
LUNDBERG, J
HEDNER, T
机构
[1] SAHLGRENS UNIV HOSP,DEPT CLIN PHARMACOL,S-41345 GOTHENBURG,SWEDEN
[2] SAHLGRENS UNIV HOSP,DEPT ORAL SURG,S-41345 GOTHENBURG,SWEDEN
[3] SAHLGRENS UNIV HOSP,DEPT PULM MED,S-41345 GOTHENBURG,SWEDEN
[4] KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN
关键词
D O I
10.1038/clpt.1992.161
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hemodynamic effects during rest and exercise of oral snuff were investigated in an open, placebo-controlled study of nine habitual users of oral snuff. Blood pressure, heart rate, and central hemodynamics were measured noninvasively. Plasma concentrations of nicotine, cotinine, norepinephrine, and epinephrine, as well as neuropeptide Y-like immunoreactivity were measured before and after snuff intake during rest and exercise. Snuff intake induced a significant increase in heart rate and blood pressure and a decrease in stroke volume during rest. Hemodynamic changes were unrelated to nicotine or cotinine concentrations. Resting levels of norepinephrine and neuropeptide Y-like immunoreactivity were similar with or without snuff, whereas epinephrine was slightly increased 30 minutes after snuff intake. The exercise-induced increase in norepinephrine and neuropeptide Y-like immunoreactivity did not differ between the days subjects received snuff and the days they received placebo. In contrast, maximum work load was associated with a slight increase in circulating epinephrine after snuff intake. The findings suggest that snuff intake is associated with significant hemodynamic effects during rest but not during exercise. These effects could not be readily explained by activation of the sympathetic nervous system.
引用
收藏
页码:394 / 401
页数:8
相关论文
共 30 条
[1]  
BENOWITZ NL, 1988, NEW ENGL J MED, V319, P873, DOI 10.1056/NEJM198809293191318
[2]   COTININE DISPOSITION AND EFFECTS [J].
BENOWITZ, NL ;
KUYT, F ;
JACOB, P ;
JONES, RT ;
OSMAN, AL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :604-611
[3]   NICOTINE ABSORPTION AND CARDIOVASCULAR EFFECTS WITH SMOKELESS TOBACCO USE - COMPARISON WITH CIGARETTES AND NICOTINE GUM [J].
BENOWITZ, NL ;
PORCHET, H ;
SHEINER, L ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) :23-28
[4]   SMOKERS OF LOW-YIELD CIGARETTES DO NOT CONSUME LESS NICOTINE [J].
BENOWITZ, NL ;
HALL, SM ;
HERNING, RI ;
JACOB, P ;
JONES, RT ;
OSMAN, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (03) :139-142
[5]  
BENOWITZ NL, 1986, ANNU REV MED, V37, P21
[6]  
BOLINDER G, 1987, TOBAKSBRUK OHALSA
[7]   NOREPINEPHRINE AND EPINEPHRINE RELEASE AND ADRENERGIC MEDIATION OF SMOKING-ASSOCIATED HEMODYNAMIC AND METABOLIC EVENTS [J].
CRYER, PE ;
HAYMOND, MW ;
SANTIAGO, JV ;
SHAH, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (11) :573-577
[8]  
CRYER PE, 1976, NEW ENGL J MED, V295, P773
[9]   AN INTERPRETATIVE REVIEW OF SMOKELESS TOBACCO RESEARCH IN THE UNITED-STATES .1. [J].
GLOVER, ED ;
SCHROEDER, KL ;
HENNINGFIELD, JE ;
SEVERSON, HH ;
CHRISTEN, AG .
JOURNAL OF DRUG EDUCATION, 1988, 18 (04) :285-310
[10]   BLOOD-PRESSURE IN SMOKERS AND NONSMOKERS - EPIDEMIOLOGIC FINDINGS [J].
GREEN, MS ;
JUCHA, E ;
LUZ, Y .
AMERICAN HEART JOURNAL, 1986, 111 (05) :932-940